Table 4 Effectiveness of vaccination against Symptomatic PCR-confirmed SARS-CoV-2 by age and sex
Crude VE (95% CI) | VE adjusted for confirmed COVID-19 history (95% CI) | ||
|---|---|---|---|
Age groups | |||
18–30 | 70% (47–83) | 73% (51–85) | |
31–40 | 54% (34–68) | 57% (38–71) | |
41–50 | 53% (32–69) | 58% (38–72) | |
51–60 | 39% (14–56) | 51% (30–65) | |
60+ | 41% (21–56) | 52% (35–65) | |
Sex | |||
Male | 59% (47–68) | 65% (53–73) | |
Female | 42% (29–52) | 51% (39–60) |